At the European Society of Human Genetics annual meeting in Copenhagen this week, several groups presented studies involving automated facial analysis software.
FDNA's Face2Gene suite analyzes phenotypic data, including facial features, from rare disease patients.
The firm's first assay will be for Hodgkin lymphoma, but a liquid biopsy test for prostate cancer has also shown strong predictive power in initial validation data.
The new institute plans to use structured clinical information to inform targeted testing in order to cut down the time to diagnosis.
The company said the divestiture to Varian Medical Systems would allow it to concentrate on investing in high-growth parts of its business.
In Science this week: imaging approach to visual epigenetic activity in the brain, and more.
A research team from Stanford University modified single-molecule microscopy to see nanoscale details of DNA.
The deal joins Systems Imagination's integrative genomic and multi-scalar data-analysis services with 3Scan's 3D reconstructive tissue imaging technology.
Groups receiving funding will be part of a Consortium for Imaging and Biomarkers to perform collaborative studies, share ideas, and leverage common resources.
The partners will provide drug discovery services, expertise, and infrastructure in a new AMRI center located in the Buffalo Medical Innovation and Commercialization Hub.
Using DNA to sketch crime victims might not be a great idea, the NYTimes says.
Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.
Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.
In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.